Burrows H L, Nakajima M, Lesh J S, Goosens K A, Samuelson L C, Inui A, Camper S A, Seasholtz A F
Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan 48109, USA.
J Clin Invest. 1998 Apr 1;101(7):1439-47. doi: 10.1172/JCI1963.
Corticotropin-releasing hormone (CRH) is the primary hypothalamic releasing factor that mediates the mammalian stress response. The CRH-binding protein (CRH-BP) is secreted from corticotropes, the pituitary CRH target cells, suggesting that the CRH-BP may modulate hypothalamic-pituitary-adrenal (HPA) axis activity by preventing CRH receptor stimulation. Transgenic mice were generated that constitutively express elevated levels of CRH-BP in the anterior pituitary gland. RNA and protein analyses confirmed the elevation of pituitary CRH-BP. Basal plasma concentrations of corticosterone and adrenocorticotropin hormone (ACTH) are unchanged, and a normal pattern of increased corticosterone and ACTH was observed after restraint stress. However, CRH and vasopressin (AVP) mRNA levels in the transgenic mice are increased by 82 and 35%, respectively, to compensate for the excess CRH-BP, consistent with the idea that CRH-BP levels are important for homeostasis. The transgenic mice exhibit increased activity in standard behavioral tests, and an altered circadian pattern of food intake which may be due to transgene expression in the brain. Alterations in CRH and AVP in response to elevated pituitary CRH-BP clearly demonstrate that regulation of CRH-BP is important in the function of the HPA axis.
促肾上腺皮质激素释放激素(CRH)是介导哺乳动物应激反应的主要下丘脑释放因子。促肾上腺皮质激素释放激素结合蛋白(CRH-BP)由促肾上腺皮质激素细胞分泌,而促肾上腺皮质激素细胞是垂体中CRH的靶细胞,这表明CRH-BP可能通过阻止CRH受体刺激来调节下丘脑-垂体-肾上腺(HPA)轴的活性。构建了在前脑垂体中组成性表达高水平CRH-BP的转基因小鼠。RNA和蛋白质分析证实了垂体CRH-BP水平的升高。基础血浆皮质酮和促肾上腺皮质激素(ACTH)浓度未发生变化,在束缚应激后观察到皮质酮和ACTH呈现正常的升高模式。然而,转基因小鼠中CRH和血管加压素(AVP)的mRNA水平分别升高了82%和35%,以补偿过量的CRH-BP,这与CRH-BP水平对体内平衡很重要的观点一致。转基因小鼠在标准行为测试中表现出活动增加,并且食物摄入的昼夜节律模式发生改变,这可能是由于大脑中的转基因表达所致。垂体CRH-BP升高时CRH和AVP的变化清楚地表明,CRH-BP的调节对HPA轴的功能很重要。